AQST Latest Quarter’s Earnings
Announce Date11/3/2026
EPS Actual (USD)-0.13
Revenue Actual (USD)7.56M
Aquestive Therapeutics Inc Earnings Dates & Reports
This page offers detailed Aquestive Therapeutics Inc earnings data including the latest Aquestive Therapeutics Inc earnings report, the upcoming Aquestive Therapeutics Inc earnings date, historical data and Aquestive Therapeutics Inc earnings call news.
AQST Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
AQST FY2025 Earnings
EPS (YoY)-0.78-53.97%
Revenue (YoY)44.55M-22.61%
Aquestive Therapeutics Inc (AQST) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 11/3/2026 | 09/2026 | -0.13/-0.12 | 7.56M/11.02M | -13.55% | -31.41% |
| 8/11/2026 | 06/2026 | -0.18/-0.10 | 13.82M/11.42M | -77.03% | 21.03% |
| 5/13/2026 | 03/2026 | -0.07/-0.14 | 14.45M/10.90M | 52.09% | 32.58% |
| 3/4/2026 | 12/2025 | -0.26/-0.13 | 13.02M/13.28M | -96.88% | -2.03% |
| 11/5/2025 | 09/2025 | -0.14/-0.13 | 12.81M/12.94M | -5.42% | -1.06% |
| 8/11/2025 | 06/2025 | -0.14/-0.17 | 10.00M/11.32M | 18.97% | -11.63% |
| 5/12/2025 | 03/2025 | -0.24/-0.17 | 8.72M/12.23M | -41.24% | -28.70% |
| 3/5/2025 | 12/2024 | -0.19/-0.14 | 11.87M/13.08M | -37.75% | -9.30% |
Aquestive Therapeutics Inc Latest Earnings Call Transcripts
Aquestive Therapeutics (AQST) Q3 2026 Earnings Call: Anaphylm FDA Review and $90.3M Cash
Aquestive Therapeutics Q3 2026 earnings call: Anaphylm awaits a March 2027 FDA decision, cash reached $90.3 million, and guidance was maintained.